HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 58.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 37,994 shares of the company's stock after acquiring an additional 13,951 shares during the quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp's holdings in HCA Healthcare were worth $12,207,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Marshall Wace LLP acquired a new stake in HCA Healthcare in the second quarter valued at $514,000. Bank of Montreal Can boosted its position in shares of HCA Healthcare by 35.9% during the 2nd quarter. Bank of Montreal Can now owns 300,296 shares of the company's stock worth $102,315,000 after purchasing an additional 79,354 shares in the last quarter. Evergreen Capital Management LLC boosted its position in shares of HCA Healthcare by 7.8% during the 2nd quarter. Evergreen Capital Management LLC now owns 1,132 shares of the company's stock worth $364,000 after purchasing an additional 82 shares in the last quarter. Public Sector Pension Investment Board lifted its position in HCA Healthcare by 67.8% in the 2nd quarter. Public Sector Pension Investment Board now owns 6,829 shares of the company's stock valued at $2,194,000 after acquiring an additional 2,760 shares in the last quarter. Finally, DRW Securities LLC purchased a new stake in HCA Healthcare in the 2nd quarter valued at about $503,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

Shares of NYSE:HCA traded up $2.86 during trading on Wednesday, reaching $404.66. 423,833 shares of the company's stock traded hands, compared to its average volume of 1,138,334. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $409.42. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The firm has a market cap of $104.43 billion, a PE ratio of 20.03, a P/E/G ratio of 1.52 and a beta of 1.67. The company has a 50-day simple moving average of $374.00 and a 200-day simple moving average of $341.69.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts' consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same period last year, the company posted $4.29 EPS. HCA Healthcare's quarterly revenue was up 10.3% compared to the same quarter last year. As a group, analysts predict that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare's payout ratio is presently 13.16%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on HCA shares. Robert W. Baird started coverage on HCA Healthcare in a research report on Thursday, May 30th. They set an "outperform" rating and a $396.00 price objective on the stock. Truist Financial increased their price objective on HCA Healthcare from $390.00 to $430.00 and gave the company a "buy" rating in a research report on Monday, August 19th. Baird R W upgraded HCA Healthcare to a "strong-buy" rating in a research report on Thursday, May 30th. Barclays raised their price target on HCA Healthcare from $376.00 to $396.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 24th. Finally, Morgan Stanley assumed coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an "equal weight" rating and a $427.00 price target on the stock. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $359.89.

Insider Activity

In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business's stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business's stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares of the company's stock, valued at $14,569,729.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.